[1]
Abualsaud, M.A. et al. 2026. Tirzepatide in Type 2 Diabetes Mellitus: A Comprehensive Review of Its Novel Dual GIP/GLP-1 Receptor Agonism, Clinical Efficacy, Safety, and Therapeutic Potential. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES. (Oct. 2026), 31–39. DOI:https://doi.org/10.29284/x84kd674.